SCHEMBL6028693

SCHEMBL6028693

Cc1nc2cc(OC[C@H](O)CN3CCC(Nc4cc(N5CCCC5=O)ccc4C(F)(F)F)CC3)ccc2s1

nearest known ligand 0.53

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6029005 0.86 CYP3A4 (0.51) CYP3A4
SCHEMBL6028411 0.79 CYP3A4 (0.56) CYP3A4
SCHEMBL6028875 0.79 CYP3A4 (0.58) CYP3A4
SCHEMBL4325409 0.78 CYP3A4 (0.49) CYP3A4
SCHEMBL4323916 0.77 CYP3A4 (0.52) CYP3A4
SCHEMBL6028331 0.76 CYP3A4 (0.52) CYP3A4
SCHEMBL4322366 0.76 CYP3A4 (0.51) CYP3A4
SCHEMBL6028724 0.76 CYP3A4 (0.51) CYP3A4
SCHEMBL4322336 0.74 CYP3A4 (0.51) CYP3A4
SCHEMBL4336885 0.73 CYP3A4 (0.65) CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1723129-A1 1-AKAN-2-OL SUBSTITUTED PIPERAZINE AND PIPERIDINE COMPOUNDS CV THERAPEUTICS, INC. (US) 2006-11-22 EP disclosed
WO-2005061470-A1 1-AKAN-2-OL SUBSTITUTED PIPERAZINE AND PIPERIDINE COMPOUNDS CV THERAPEUTICS, INC. (US) 2005-07-07 WO disclosed